ArticleMolecular genetics & genomic medicine2025
A Novel YWHAG Variant L173S Causes Developmental and Epileptic Encephalopathy by Disrupting the Hydrophobic Internal Protein Structure.
Article in Molecular genetics & genomic medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDevelopmental epileptic encephalopathy 56 (DEE56) is a monogenic DEE type caused by heterozygous mutations in YWHAG. To our knowledge, fewer than 30 cases of DEE56 have been reported globally, and our understanding of YWHAG's function remains limited.
methodsWhole exome sequencing (WES) was performed on the patient and his parents. Structural conservation analysis of YWHAG was conducted using Consurf and PyMol. A literature search for relevant cases was performed in PubMed and Google Scholar.
resultsThe patient is a 6-year-2-month-old boy who developed refractory complex seizures starting at 8 months of age. He also exhibits intellectual disability, language impairment, and poor motor coordination. WES identified the de novo occurrence of a novel heterozygous YWHAG missense variant, c.518T>C (p.L173S), in the patient. L173 resides within the hydrophobic internal core formed by three alpha helices of YWHAG, and the residues constituting this internal core are highly evolutionarily conserved. The L173S substitution introduces a hydrophilic side chain into the hydrophobic core composed of three aliphatic residues. Ten missense mutations have been reported previously. Among them, five (E15, R57, D129, R132, and Y133) are associated with the ligand-binding region.
conclusionThe functional domain involving the L173 residue of YWHAG remains unknown. Our findings suggest that the disruption of the stability of the highly conserved internal core of the YWHAG protein may be one mechanism leading to functional impairment, distinct from the previously proposed pathogenic models of dimer formation defects and/or impaired binding to phosphopeptide ligands. This may provide insights into the functional mechanisms of YWHAG and potential therapeutic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.